Pentavalent DTP-Hib-HBV vaccine (BioNet-Asia)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePentavalent DTP-Hib-HBV vaccine (BioNet-Asia)
Drug Alias NameDiphtheria-pertussis-tetanus-Hemophilus influenzae type B-hepatitis B virus vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BTetanusDiphtheria +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBionet-Asia Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionet-Asia Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis BTetanusDiphtheria +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA11
Related LinksN/A